
Sign up to save your podcasts
Or


Showing an association is not enough to determine causation.
Roche’s gene therapy drug Rugonersen boosts expression of the protein missing in the syndrome in mice and monkeys, but whether it works in people remains to be seen.
What these genes do and how they affect autism depends on when in development they’re studied, despite what classic ‘gene ontology’ analyses say.
The new tool may help researchers reconstruct the sequence of biological events that underlie development.
Troves of sequencing data reveal genes tied to autism through different variant types, providing a more complete picture of the condition’s genetic roots and new clues to its heterogeneity.
From the publisher's feed

43,801 Listeners

7,611 Listeners

8,749 Listeners

1,979 Listeners

542 Listeners

420 Listeners

172 Listeners

10 Listeners

111,874 Listeners

56,435 Listeners

6,586 Listeners

5,549 Listeners

29,191 Listeners

15,917 Listeners

1,652 Listeners

9 Listeners

752 Listeners